Anika Therapeutics Inc
ANIK9.750USD
-0.100-1.02%
Cierre 11/06, 16:00（ET）Cotizaciones retrasadas 15 min
140.58MCap. mercado
PérdidaP/E TTM
Más Datos de Anika Therapeutics Inc Compañía
Anika Therapeutics, Inc. is a global joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. It is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.
Información de Anika Therapeutics Inc
Símbolo de cotizaciónANIK
Nombre de la empresaAnika Therapeutics Inc
Fecha de salida a bolsaMay 16, 1985
Director ejecutivoDr. Cheryl Renee Blanchard, Ph.D.
Número de empleados288
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 16
Dirección32 Wiggins Ave
CiudadBEDFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01730-2315
Teléfono17814579000
Sitio Webhttps://anika.com/
Símbolo de cotizaciónANIK
Fecha de salida a bolsaMay 16, 1985
Director ejecutivoDr. Cheryl Renee Blanchard, Ph.D.
Ejecutivos de Anika Therapeutics Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Mr. Ian McLeod
Mr. Ian McLeod
Chief Accounting Officer, Vice President, Treasurer
Chief Accounting Officer, Vice President, Treasurer
--
--
Mr. Gary P. Fischetti
Mr. Gary P. Fischetti
Independent Director
Independent Director
--
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
OEM Channel
16.34M
57.90%
Commercial Channel
11.88M
42.10%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
17.92M
63.52%
Other
5.54M
19.64%
Europe
4.75M
16.84%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
OEM Channel
16.34M
57.90%
Commercial Channel
11.88M
42.10%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
Otro
59.69%
Accionistas
Accionistas
Proporción
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
Otro
59.69%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
37.86%
Investment Advisor/Hedge Fund
27.04%
Investment Advisor
23.18%
Individual Investor
4.88%
Research Firm
1.06%
Pension Fund
0.45%
Bank and Trust
0.13%
Insurance Company
0.03%
Otro
5.37%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
261
13.09M
90.76%
-1.17M
2025Q2
302
13.74M
95.32%
-1.50M
2025Q1
310
13.52M
94.22%
-1.59M
2024Q4
308
13.33M
91.05%
-2.02M
2024Q3
309
13.98M
94.53%
-1.95M
2024Q2
313
14.09M
95.06%
-2.05M
2024Q1
312
14.07M
96.09%
-1.66M
2023Q4
314
13.84M
94.50%
-1.88M
2023Q3
309
13.57M
92.73%
-2.13M
2023Q2
310
13.73M
93.04%
-2.32M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Trigran Investments, Inc.
2.04M
14.12%
-5.34K
-0.26%
Jun 30, 2025
Caligan Partners, LP
1.44M
9.95%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
937.30K
6.5%
-20.13K
-2.10%
Jun 30, 2025
The Vanguard Group, Inc.
779.47K
5.41%
+2.07K
+0.27%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
623.08K
4.32%
+9.11K
+1.48%
Jun 30, 2025
Opaleye Management Inc.
588.80K
4.08%
+193.80K
+49.06%
Jun 30, 2025
Acadian Asset Management LLC
575.64K
3.99%
+36.03K
+6.68%
Jun 30, 2025
The Capital Management Corporation
408.85K
2.84%
+79.19K
+24.02%
Jun 30, 2025
BlackRock Financial Management, Inc.
546.12K
3.79%
+24.11K
+4.62%
Jun 30, 2025
Boothbay Fund Management, LLC
529.50K
3.67%
--
--
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: hace 20 horas
Actualizado: hace 20 horas
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.48%
Royce Quant Small-Cap Quality Value ETF
0.21%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.09%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.48%
Royce Quant Small-Cap Quality Value ETF
Proporción0.21%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporción0.09%
iShares Micro-Cap ETF
Proporción0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.01%
Avantis US Small Cap Equity ETF
Proporción0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.01%
WisdomTree US SmallCap Fund
Proporción0.01%
iShares Russell 2000 Value ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
